The goal of this project is to understand in mechanistic terms how proteins are transported across membranes. One aspect of this proposal is to clarify how proteins are translocated co- or post-translationally from the cytosol across the bacterial plasma membrane. We have determined X-ray and electron-microscopy (EM) structures of the protein-conducting SecY channel, with and without a ribosome-nascent chain complex or the ATPase SecA, and used biochemical experiments to study translocation, providing the basis for the present proposal. In eukaryotes, there is a retro-translocation pathway, called ERAD (for ER associated degradation). We have used purified S. cerevisiae components to reconstitute key steps in ERAD-L used by luminal ER proteins, paving the way for mechanistic studies. Here, we will address central questions in protein translocation: 1. how are proteins cotranslationally translocated? Based on new methods to purify translocation intermediates generated in intact E. coli cells, we will use single- particle cryo-EM to determine how the active channel binds to the ribosome, how the signal sequence binds to the SecY channel, and how the channel opens during translocation. 2. What is the mechanism of posttranslational translocation in bacteria? We will use single-molecule and optical tweezers experiments to test a recently proposed push and slide model in which SecA, upon ATP-binding, pushes a subset of amino acids into the SecY channel and allows passive sliding of the polypeptide in its ADP-bound state. We will use X-ray crystallography to determine how a signal sequence of a post-translational substrate binds to the SecY channel. 3. What is the molecular mechanism of retro-translocation in ERAD-L? We will use in vitro systems with purified ERAD components to determine how proteins are retro-translocated and extracted from the membrane. We will reproduce the substrate specificity observed in wild type cells, analyze the mechanism of individual ERAD-L steps, and determine the specific functions of ERAD components. In vivo experiments in S. cerevisiae will be used to test results obtained in vitro. The mechanism of protein translocation is of great medical importance. Drugs that inhibit signal sequence binding can be used for therapeutic intervention in chronic inflammatory diseases. A large number of diseases, including cystic fibrosis and a1-antitrypsin deficiency, are caused by mutations that result in the misfolding of ER proteins and their subsequent degradation in the cytosol. The pathway is also hijacked by certain viruses and toxins, and a better understanding may lead to new drugs allowing interference.

Public Health Relevance

The translocation of proteins across membranes is a fundamental process involved in the biosynthesis and degradation of a large class of proteins. The medical importance of translocation is demonstrated by drugs that inhibit signal sequence binding, which are used for therapeutic intervention in chronic inflammation, as well as by the large number of diseases, including cystic fibrosis and a1-antitrypsin deficiency, which result from the misfolding of ER proteins and their subsequent degradation in the cytosol. A better understanding of the translocation process both in the forward and backward direction may elucidate the causes of these diseases and result in the development of drugs that allow selective interference.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM052586-22
Application #
9037674
Study Section
Membrane Biology and Protein Processing Study Section (MBPP)
Program Officer
Ainsztein, Alexandra M
Project Start
1995-05-01
Project End
2019-03-31
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
22
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Harvard Medical School
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
Schoebel, Stefan; Mi, Wei; Stein, Alexander et al. (2017) Cryo-EM structure of the protein-conducting ERAD channel Hrd1 in complex with Hrd3. Nature 548:352-355
Bodnar, Nicholas O; Rapoport, Tom A (2017) Molecular Mechanism of Substrate Processing by the Cdc48 ATPase Complex. Cell 169:722-735.e9
Tripathi, Arati; Mandon, Elisabet C; Gilmore, Reid et al. (2017) Two alternative binding mechanisms connect the protein translocation Sec71-Sec72 complex with heat shock proteins. J Biol Chem 292:8007-8018
Baldridge, Ryan D; Rapoport, Tom A (2016) Autoubiquitination of the Hrd1 Ligase Triggers Protein Retrotranslocation in ERAD. Cell 166:394-407
Li, Long; Park, Eunyong; Ling, JingJing et al. (2016) Crystal structure of a substrate-engaged SecY protein-translocation channel. Nature 531:395-399
Tan, Dongyan; Blok, Neil B; Rapoport, Tom A et al. (2016) Structures of the double-ring AAA ATPase Pex1-Pex6 involved in peroxisome biogenesis. FEBS J 283:986-92
Chen, Yu; Seepersaud, Ravin; Bensing, Barbara A et al. (2016) Mechanism of a cytosolic O-glycosyltransferase essential for the synthesis of a bacterial adhesion protein. Proc Natl Acad Sci U S A 113:E1190-9
Chen, Yu; Bauer, Benedikt W; Rapoport, Tom A et al. (2015) Conformational Changes of the Clamp of the Protein Translocation ATPase SecA. J Mol Biol 427:2348-59
Junne, Tina; Wong, Joanne; Studer, Christian et al. (2015) Decatransin, a new natural product inhibiting protein translocation at the Sec61/SecYEG translocon. J Cell Sci 128:1217-29
Bauer, Benedikt W; Shemesh, Tom; Chen, Yu et al. (2014) A ""push and slide"" mechanism allows sequence-insensitive translocation of secretory proteins by the SecA ATPase. Cell 157:1416-29

Showing the most recent 10 out of 37 publications